Clinical Trial Update: A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of etrolizumab in ulcerative colitis patients previously treated with TNF inhibitors has completed with posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Etrolizumab (etrolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2021-06-15